|
|
|
|
| As the patient’s immune cells are the starting materials, inherent biological variability leads to CAR-T manufacturing. Additional critical raw materials also have batch-to-batch variability, which means the entire production process is a constant balancing act of adjusting the manufacturing process to create standardized manufacturing. Join Cell & Gene Live for a discussion on practical ways to overcome the challenges associated with batch-to-batch variation. Registration is free thanks to the support of Entegris. |
|
|
|
|
By Moshe Szyf, Ph.D., founder, HKG Epitherapeutics Ltd. | Epigenetic programming allows two genes with identical sequences to function differently. One crucial mechanism in this process is DNA methylation. This author explores how environmental exposures in early life could potentially modify the DNA methylation of crucial genes responsible for regulating sugar and metabolism. |
|
|
|
|
| How To Reduce 5 Key Risks In Fill/Finish | Infographic | Terumo BCT | Explore how automation and best practice solutions can help cell therapy manufacturers de-risk their fill/finish process and produce strong, consistent results. |
|
|
| Considerations For Media And Mixing | Article | By Ahmed Abouzeid and David Menahem, Sartorius | Regardless of phase, media and mixing optimization can afford operators speed and efficiency for drug processing; likewise, failing to prioritize media preparation can compromise a process. |
|
|
| Automating And Optimizing The Cell Harvesting Process | Application Note | Cytiva | Optimizing cell harvesting in a closed and automated manner is important to reduce processing time. Discover how this type of automation can minimize the potential for cell loss during wash steps. |
|
|
|
| Advancements In Critical Cleanroom Components | Article | G-CON | The demand for modular cleanroom doors and panels in the United States is leading to new turnkey cleanroom solutions. Uncover three factors driving this demand and the opportunities prefab provides. |
|
|
|
|
|
|
| Unlocking The Truth Behind Large CROs: Exposing The Great Talent Misconception | Large CROs have a vast pool of resources and a subset of amazingly talented people. However, the decision to select such a CRO on the concept that they have access to the best talent, and the hope that those resources will be assigned to your study, is flawed. Discover ways to overcome those faults by creating a culture where excellence, grit, and patient centricity thrive. |
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
